This pilot study is being done to determine if the nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device can be used in the treatment of OSA in adults. The researchers think that the NPA-OSA device will reduce the number of apneas.
Capacity and willingness to sign consent
Patient willingness to commit to and complete study over a 30-day time period
Confirmed diagnosis of moderate to severe OSA (AHI >= 15)
OSA caused by upper airway obstruction
Within 3 months of initiating CPAP use, and actively using CPAP
Supraglottic airway collapse
Distal airway stenosis
Tracheobronchomalacia
University of Michigan
Lead sponsor
Wallace H Coulter Center for Translational Research
Collaborator